Drugs / Seasonal TIV
Seasonal TIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01709019 | Oct 2012 → Jul 2013 | respiratory syncytial virus infectious disease | Novavax | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seasonal TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01709019 ↗ |
| Known as | licensed inactivated trivalent influenza vaccine | “licensed inactivated trivalent influenza vaccine (TIV)” PMID 28413427 ↗ Apr 2017 |
| Known as | TIV | “licensed inactivated trivalent influenza vaccine (TIV)” PMID 28413427 ↗ Apr 2017 |
| Modality | Vaccine | “licensed inactivated trivalent influenza vaccine (TIV)” PMID 28413427 ↗ Apr 2017 |
| Route | Intramuscular | “0.5mL IM injections” NCT01709019 ↗ |